Chronic Lymphocytic Leukemia Clinical Trials in Bordeaux
3 recruitingBordeaux, France
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeOne Medicines500 enrolled129 locationsNCT06973187
Recruiting
Phase 1Phase 2
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma+6 more
BeOne Medicines614 enrolled120 locationsNCT05006716
Recruiting
Determinants of the Response to BTK Degraders (BTKd) in Double Refractory CLL
Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia
Nantes University Hospital60 enrolled14 locationsNCT07099443